StockSelector.com
  Research, Select, & Monitor Thursday, October 18, 2018 10:17:50 AM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
Tenax Therapeutics, Inc.$4.90$.051.03%

  Quote | Ranking | Chart | Valuations | Sentiment | Industry | News | Earnings | Analysts | More...

Your Target?

Income Statement for Tenax Therapeutics, Inc.
(Amounts are in millions) 12/2017 12/2016 12/2015
Press Release
Net Sales or Revenues $0.00 $0.00 $0.04
Cost of Goods Sold $0.00 $0.00 $0.00
Gross Profit $0.00 $0.00 $0.04
       
Research & Development Expense $3.53 $13.14 $13.14
Selling, General, & Admin. Expense $5.68 $39.51 $12.14
Income Before Depreciation ($9.21) ($52.65) ($25.24)
       
Depreciation, Depletion, Amortization $0.00 $0.00 $0.00
Non-Operating Income $0.37 $8.73 $1.14
Interest Expense $0.00 $0.00 $0.05
Pretax Income ($8.84) ($43.92) ($24.14)
       
Provision for Income Taxes $0.00 $0.00 $0.00
Minority Interest $0.00 $0.00 $0.00
Investment Gains (Losses) $0.00 $0.00 $0.00
Other Income $0.00 $0.00 $0.00
Income Before Extraordinaries ($8.84) ($43.92) ($24.14)
       
Extraordinary Items & Disc. Operations $0.00 $0.00 $0.00
Net Income ($8.84) ($43.92) ($24.14)
       
Basic Earnings Per Share ($6.27) ($31.20) ($17.17)
Diluted Earnings Per Share ($6.27) ($31.20) N/A
       
Weighted Average Basic Shares Outstanding N/A 1.41 N/A
Weighted Average Diluted Shares Outstanding N/A 1.41 N/A
       
Income Before Non-Recurring Items N/A ($18.62) N/A
Income From Non-Recurring Items N/A ($25.30) N/A
Diluted Earnings Per Share before extras N/A ($13.20) N/A
       
Dividend (preferred) N/A N/A N/A
Dividend (common) $0.00 $0.00 $0.00
Dividend Per Share (common) $0.00 $0.00 $0.00




Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2018 StockSelector.com. All rights reserved.